News Summary:
On February 12, 2026, Welocalize discussed how AI-enabled tools have fundamentally altered modern product development, enabling ideas to reach production in days, sometimes faster. Previously, on January 22, 2026, the company highlighted the mandatory use of the first four EUDAMED modules for medical device companies by May 28, 2026, significantly raising transparency requirements across the EU medical technology market. Earlier, on December 17, 2025, Welocalize announced a strategic partnership with Phrase, embedding Welocalize’s OPAL Platform natively within the Phrase Platform. This collaboration aims to bring agentic AI systems into one of the industry’s most widely used language technology platforms, creating a more unified, streamlined environment for enterprise teams managing multilingual content. In November 2025, Welocalize explored the importance of translation in patent strategy, examining how legal teams use data and technology to strengthen patent filings and protect innovation globally. This followed a discussion on November 12, 2025, where Welocalize emphasized that building trustworthy agentic AI systems relies on diverse, high-quality training data, identifying autonomous agents as the next wave of artificial intelligence.
Subscribe for full access to Welocalize's profile
Subscribe for full access to Welocalize's products in full detail 
